“2,07,229 more people were vaccinated on the first day, the number of first-day vaccinations in the world,” said Manohar Agnani, additional secretary of the Ministry of Health and Family at the meeting. “This is much higher than in many other countries like the United States, the United Kingdom and France,” he added.

A total of 2,24,301 beneficiaries have been vaccinated with the COVID-19 vaccine so far, the ministry said. On Sunday, 17,072 beneficiaries were vaccinated across the country. “Today, six states conducted a vaccination crusade and in 553 sessions, a total of 17,072 beneficiaries were vaccinated,” Agnani said.

Vaccination took place Sunday in six states: Andhra Pradesh (308 sessions), Arunachal Pradesh (14 sessions), Karnataka (64 sessions), Kerala (one session), Manipur (one session) and Tamil Nadu (165 sessions). Said.

To date, at least 447 cases of adverse events have been reported after vaccination, according to data from the Ministry of Health. “A total of 447 MAPIIs were reported on January 16 and 17, of which only 3 required hospitalization. Most MAPI reported that yes, minor, like fever, headache, nausea,” he said.

“The other 3 people hospitalized after vaccination, two have been discharged from the Northern Railway Hospital and AIIMS in Delhi and one is at AIIMS Rishikesh and is fine,” the supplementary secretary said.

He also commented that a post-vaccination adverse occasion (MAPI) is any medical occasion unforeseen after vaccination and would possibly not be similar to the vaccine or vaccination process.

Noting that only a few MAPI cases would possibly require hospitalization that are classified as severe MAPI, Agnani stated that protocols are in a position to report, rapid case control at the time of the vaccination session, transportation and hospitalization, and additional care for those cases.

“Protocols are in position for systematic investigation and evaluation of the causality of severe MAPI (cases),” he said.

An assembly held on Sunday with all EU states and territories to review campaign progress, identify bottlenecks and plan corrective actions, he said.

India has granted emergency use authorization (USA) to two COVID-19 vaccines: the Serum Institute of India in Covishield, Covishield, and the Covaxin of Bharat Biotech International Ltd in Hyderabad, which are used in the government’s vaccination campaign.

Click here to read that Mint ePaperMint is now on Telegram. Join the Mint Channel on your Telegram and updated with the latest commercial news.

Log in to our to save your favorites. It’ll only take a moment.

Ups! Turns out you’ve exceeded the limit of the symbol’s favorite. Remove some to upload this symbol to your favorites.

Your query has expired, reconnect.

You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder.